Interventional cardiology in a whole new light

Open menu

News & Events

Meet Opsens at Euro PCR – Paris, May 22-25 2018 – Attend our session: New technologies to make the difference in complex PCI

16 May 2018

Hear, see and feel the OptoWire® Deux difference at Euro PCR 2018 in Paris, France. Visit Opsens’ Booth M60 on the 2nd floor (facing room Maillot) Meet the experts, experience an OptoWire demonstration, and learn more about The OptoWire® One-Wire PCI™ Program! Also, attend our Scientific session: Case In Point session sponsored by Opsens Medical and…

Read more

OPSENS APPLAUDS JAPANESE GOVERNMENT NEW REGULATION SUPPORTING DIAGNOSIS, SUCH AS FFR, BEFORE TREATMENT OF CORONARY STENOSIS

24 April 2018

Quebec City, Quebec, April 24, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) applauds Japan’s Ministry of Health, Labor and Welfare (“MHLW”) on its new regulation requiring the evaluation of any coronary stenosis prior to its treatment, specifically mentioning Fractional Flow Reserve (“FFR”) as a preferred assessment method. The MHLW recently revised medical…

Read more

84th German Cardiac Society Annual Meeting in Mannheim 2018

30 March 2018

Opsens sponsored Symposium: Clinical value of FFR and adenosine-free alternatives in the cathlab Our Distributor, Bisping Medizintechnik GmbH will showcase the Opsens technology at German Cardiac Societies Annual Meeting in Mannheim, Germany, from April 4th to 7th, 2018. They will show the innovative, fast and easy-to-use OptoMonitor FFR system together with the best-in-class optical OptoWire…

Read more

VISIT OPSENS MEDICAL AT SCAI 2018

10 March 2018

Learn more about the benefits of OptoWire as a workhorse wire at the Society for Cardiovascular Angiography and Interventions – SCAI 2018 by visiting us at the Opsens booth (#603) or joining us at one of the following: Attend the Poster Session II, “Functional Optimization of Coronary Intervention Using Post-PCI Fractional Flow Reserve: A Prospective…

Read more

SIF 2018 – OPSENS MEDICAL ON EXHIBIT! March 21-24, 2018

27 February 2018

Hear, see and feel the OptoWire® Deux difference at SIF 2018 in Scottsdale, Arizona. Visit the Opsens Medical booth to meet the experts, experience an OptoWire demonstration, and learn more about The OptoWire® One-Wire PCI™ Program!

ATTEND THE OPSENS MEDICAL SPONSORED SYMPOSIUM AT THE CRT 2018 CONFERENCE

19 February 2018

Attend the Opsens sponsored complimentary lunch educational symposium, “Upgrading Coronary Physiologic Approaches: Methods, Myths, and Best Practices” at CRT (Cardiovascular Research Technologies) 2018 Conference in Washington, DC. Opsens offers the first fiber-optic FFR guidewire with nitinol core, providing superior handling, functionality and accuracy, particularly beneficial in complex PCI. Leading experts in coronary physiology will demonstrate clinical utility…

Read more

OPSENS ANNOUNCES ELECTION RESULTS FOR THE BOARD OF DIRECTORS AND THE RETIREMENT OF CLAUDE BELLEVILLE

23 January 2018

  Quebec City, Quebec, January 23, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today held its annual general shareholders’ meeting (the “Meeting”) at its head office in Quebec City, Canada. Opsens’ shareholders re-elected Denis M. Sirois, Denis Harrington, Pat Mackin, Jean Lavigueur, Gaétan Duplain and Louis Laflamme as members of the Board…

Read more

OPSENS REPORTS Q1 2018 RESULTS – RECORD QUARTERLY REVENUES WITH GROWTH IN ALL GEOGRAPHIC REGIONS

16 January 2018

Quebec City, Quebec, January 15, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the first quarter ended November 30, 2017. Highlights Consolidated revenues reached $6,364,000 for Q1 2018 compared with $3,745,000 for the same period last year, an increase of $2,619,000 or 70%; Fractional Flow Reserve (“FFR”) revenues…

Read more

OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE

27 November 2017

Quebec City, Quebec, November 27, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) is pleased to announce the conversion of the US$2 million debenture held by Zeon Medical Inc. (“Zeon Medical”), Opsens’ Japanese partner. Zeon Medical has been a client of Opsens since 2004. In 2012, Opsens granted Zeon Medical the exclusive distribution rights for…

Read more

OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017

15 November 2017

  OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017 Quebec City, Quebec, November 15, 2017 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2017. Highlights Record consolidated revenues for fiscal year 2017 at $17.8 million; Revenues for Fractional Flow Reserve (“FFR”)…

Read more